TGFTX-3

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTGFTX-3
Drug Alias NameTGFTX-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor subfamily 1 group D member 1 stimulants
TargetsNuclear receptor subfamily 1 group D member 1
Therapy Area/IndicationsNerve DegenerationInflammationMetabolic Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenfit SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenfit SA
Active IndicationsN/A
Inactive IndicationsNerve DegenerationInflammationMetabolic Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A